S-allylcysteine Improves Blood Flow Recovery and Prevents Ischemic Injury by Augmenting Neovasculogenesis
Studies suggest that a low level of circulating human endothelial progenitor cells (EPCs) is a risk factor for ischemic injury and coronary artery disease (CAD). Consumption of S-allylcysteine (SAC) is known to prevent CAD. However, the protective effects of SAC on the ischemic injury are not yet cl...
Main Authors: | Jia-Ning Syu, Mei-Due Yang, Shu-Yao Tsai, En-Pei Isabel Chiang, Shao-Chih Chiu, Che-Yi Chao, Raymond L. Rodriguez, Feng-Yao Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-10-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689717724792 |
Similar Items
-
INTRACAROTIDAL GRAFTS OF HUMAN DENTAL PULP STEM CELLS CONTRIBUTE TO BRAIN NEOVASCULOGENESIS AFTER ISCHEMIC STROKE
by: Leire Oyon, et al.
Published: (2023-10-01) -
Preparation, Characterization, and In Vitro Evaluation of Inclusion Complexes Formed between S‑Allylcysteine and Cyclodextrins
by: Rino Tachikawa, et al.
Published: (2022-08-01) -
A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma.
by: Kevin T P Ng, et al.
Published: (2012-01-01) -
S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1
by: Yasi Xu, et al.
Published: (2018-05-01) -
The shortest innovative process for enhancing the S-allylcysteine content and antioxidant activity of black and golden garlic
by: Peeraporn Pakakaew, et al.
Published: (2022-07-01)